Search
Quote for "exact phrases"
       
Sort order:    
Results 1 - 50 of 77

Long-Acting Injectable Antipsychotics Linked to Lower Early Rehospitalization in Bipolar I Disorder
This Month in Psychpharmacology added 08/07/2026. CME credit is not available

Novel M1/M4 Agonist Demonstrates Phase 2 Efficacy in Schizophrenia
This Month in Psychpharmacology added 07/27/2026. CME credit is not available

Changing Course: Improving the Prognosis in Chronic, Serious Mental Illness With Early Adoption of Long-Acting Injectables
Encore Presentation added 06/29/2026. CME credit is available

A Novel D2/D3/5-HT7 Antagonist Shows Promise in Acute Schizophrenia
This Month in Psychpharmacology added 06/18/2026. CME credit is not available

World Schizophrenia Day: Education & Resources
This Month in Psychpharmacology added 05/23/2026. CME credit is not available

Chatbots Reinforce Users’ Psychotic Ideations
This Month in Psychpharmacology added 05/18/2026. CME credit is not available

The Nitty Gritty of LAI Delivery
Encore Presentation added 03/27/2026. CME credit is available

Worth a Shot? Practical Guidance and Patient Perspectives on Long-Acting Injectables
Encore Presentation added 03/27/2026. CME credit is available

FDA Accepts New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension
This Month in Psychpharmacology added 03/09/2026. CME credit is not available

Of Musc and Men: The Exciting Potential of Muscarinic Receptor Modulation in the Treatment of Schizophrenia
Encore Presentation added 01/30/2026. CME credit is available

Solutions to Common Issues in the Use of Long-Acting Injectable Antipsychotics
CNS Spectrums added 12/31/2025. CME credit is available

Understanding Long-Acting Injectable Antipsychotics in the Context of Treatment Planning: Crafting a Strategy
CNS Spectrums added 12/31/2025. CME credit is available

Long-Acting Injectable Antipsychotics for Patients With First-Episode and Early-Phase Schizophrenia: Still Not Considered Often Enough
CNS Spectrums added 12/28/2025. CME credit is available

Lies and LAIs: Why Accuracy of Information is the Key to Understanding the Benefits and the Resistance to Using Long-acting Formulation
CNS Spectrums added 12/27/2025. CME credit is available

Prescribing LAIs: From Completing the First Injection to Going Steady
CNS Spectrums added 12/26/2025. CME credit is available

Choosing Amongst the Long-Acting Injectable Antipsychotics: An Evidence-Based Pragmatic Guide
CNS Spectrums added 12/24/2025. CME credit is available

Relapse Criteria in Schizophrenia
This Month in Psychpharmacology added 12/02/2025. CME credit is not available

Switching from Oral Risperidone to Risperidone Subcutaneous
Switching and Deprescribing added 10/31/2025. CME credit is not available

Switching from Oral Paliperidone to Paliperidone Palmitate (1M, Sustenna)
Switching and Deprescribing added 10/31/2025. CME credit is not available

Switching from Oral Paliperidone to Paliperidone Palmitate (1M, Erzofri)
Switching and Deprescribing added 10/31/2025. CME credit is not available

Switching from Oral Aripiprazole to Aripiprazole Monohydrate
Switching and Deprescribing added 10/31/2025. CME credit is not available

Switching from Oral Aripiprazole to Aripiprazole Lauroxil
Switching and Deprescribing added 10/31/2025. CME credit is not available

Long-Acting Injectable (LAI) Antipsychotic Formulations
Medication Tips and Pearls added 10/31/2025. CME credit is not available

Switching from Oral Haloperidol to Haloperidol Decanoate
Switching and Deprescribing added 10/31/2025. CME credit is not available

SSRIs and SNRIs Lower Relapse in Clozapine Treated Schizophrenia
This Month in Psychpharmacology added 09/26/2025. CME credit is not available

Clozapine Shows Greater Benefit in Schizoaffective Disorder
This Month in Psychpharmacology added 08/23/2025. CME credit is not available

You and I and an LAI: Benefits, Early Adoption, and Options for Patients With Serious Mental Illness
Encore Presentation added 08/01/2025. CME credit is available

Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders
Encore Presentation added 06/06/2025. CME credit is available

Exciting Advances in Our Understanding of Glutamatergic Neurotransmission in Mental Illness
Encore Presentation added 06/05/2025. CME credit is available

Outside the Box: Upstream Muscarinic Modulation of Downstream Dopamine
Encore Presentation added 06/05/2025. CME credit is available

Valbenazine in Elderly Adults with Tardive Dyskinesia
This Month in Psychpharmacology added 06/04/2025. CME credit is not available

LAI Pearls: It's All About Kinetics and Collaboration
Encore Presentation added 05/02/2025. CME credit is available

Population Study Reveals Most Effective Antipsychotic Strategies for First-Episode Schizophrenia
This Month in Psychpharmacology added 02/16/2025. CME credit is not available

Breaking the Cycle: Optimizing Treatment Strategies for Serious Mental Illness in Order to Prevent Criminal Institutionalization
Encore Presentation added 12/27/2024. CME credit is available

Antipsychotic Polypharmacy on the Rise
This Month in Psychpharmacology added 12/17/2024. CME credit is not available

Mortality Risk In Long-Acting Injectable Versus Oral Antipsychotics In Schizophrenia
This Month in Psychpharmacology added 09/12/2024. CME credit is not available

Long-Acting Injectable Antipsychotics in the Geriatric Population
This Month in Psychpharmacology added 08/12/2024. CME credit is not available

Long-Term Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia
This Month in Psychpharmacology added 07/31/2024. CME credit is not available

Long-Acting Injectables
Treatment and Testing Guides added 07/22/2024. CME credit is not available

There Might Be a Little Dust on the Bottle: Long-Acting Injectables as a Strategy to Improve Antipsychotic Treatment Adherence
Encore Presentation added 07/01/2024. CME credit is available

Level Up! Using Plasma Levels, Pharmacokinetics, and Pharmacodynamics to Guide Antipsychotic Prescribing
Encore Presentation added 04/30/2024. CME credit is available

Long-Acting Injectable Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations
This Month in Psychpharmacology added 02/29/2024. CME credit is not available

Get to the Point: Utilizing Long-Acting Injectable Antipsychotics to Improve Adherence and Prevent Relapse
Encore Presentation added 12/22/2023. CME credit is available

This Year in Psychopharmacology: 2023
MPP: Articles added 12/19/2023. CME credit is available

SMI Among Us: Treating Serious Mental Illness in the Community
Encore Presentation added 12/12/2023. CME credit is available

The Long Haul: Long-Term Use of Antipsychotic Treatment in Schizophrenia
Encore Presentation added 12/12/2023. CME credit is available

Dopamine Partial Agonists: How They Work and Why They Don't Always Play Nice with Other Antipsychotics
Encore Presentation added 08/02/2023. CME credit is not available

Give It a Shot: Long-Acting Injectables for Schizophrenia and Bipolar Disorder
Encore Presentation added 05/31/2023. CME credit is not available

FDA Approves Slow-Release Long-Acting Injectable of Risperidone
This Month in Psychpharmacology added 05/05/2023. CME credit is not available

FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder
This Month in Psychpharmacology added 05/05/2023. CME credit is not available

<< Back   1 2   Next >>